Pennsylvania Appeals Court Affirms $4.2M Topamax Birth Defect Verdict

(August 21, 2015, 1:05 PM EDT) -- PHILADELPHIA — A Pennsylvania Superior Court panel on Aug. 20 affirmed a $4.2 million Topamax birth defect verdict, a ruling that turned on whether the trial judge violated Virginia law in his instructions on the causation standard (April Czimmer v. Janssen Pharmaceuticals, Inc., No. 459 EDA 2014, Pa. Super.).

(Majority opinion available. Document #28-150903-003Z. Dissent available. Document #28-150903-004Z.)

In 2006, April Czimmer, a Virginia resident, was prescribed Topamax to treat her migraines. She continued taking Topamax until February 2007.

At that time, Topamax was classified as...
To view the full article, register now.